IP-6 infringement
This article was originally published in The Tan Sheet
Executive Summary
BNG Enterprises and Lifesource Naturals settle infringement lawsuits filed by supplement maker Enzymatic Therapy and Abulkalam Shamsuddin, MD/PhD. BNG and Lifesource are enjoined from selling products combining inositol and inositol hexaphosphate (IP-6) for the remaining term of the '833 patent, according to consent orders entered in Baltimore, Md. federal court. Enzymatic's Cell Forte with IP-6 & Inositol is covered by the '833 patent, which it licenses from Shamsuddin
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning